Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020.
Gidding HF, Machalek DA, Hendry AJ, Quinn HE, Vette K, Beard FH, Shilling HS, Hirani R, Gosbell IB, Irving DO, Hueston L, Downes M, Carlin JB, O'Sullivan MV, Dwyer DE, Kaldor JM, Macartney K. Gidding HF, et al. Among authors: irving do. Med J Aust. 2021 Mar;214(4):179-185. doi: 10.5694/mja2.50940. Epub 2021 Feb 3. Med J Aust. 2021. PMID: 33538019 Free PMC article.
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey.
Vette KM, Machalek DA, Gidding HF, Nicholson S, O'Sullivan MVN, Carlin JB, Downes M, Armstrong L, Beard FH, Dwyer DE, Gibb R, Gosbell IB, Hendry AJ, Higgins G, Hirani R, Hueston L, Irving DO, Quinn HE, Shilling H, Smith D, Kaldor JM, Macartney K. Vette KM, et al. Among authors: irving do. Open Forum Infect Dis. 2022 Jan 31;9(3):ofac002. doi: 10.1093/ofid/ofac002. eCollection 2022 Mar. Open Forum Infect Dis. 2022. PMID: 35169588 Free PMC article.
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays.
Walker GJ, Naing Z, Ospina Stella A, Yeang M, Caguicla J, Ramachandran V, Isaacs SR, Agapiou D, Bull RA, Stelzer-Braid S, Daly J, Gosbell IB, Hoad VC, Irving DO, Pink JM, Turville S, Kelleher AD, Rawlinson WD. Walker GJ, et al. Among authors: irving do. Viruses. 2021 Feb 4;13(2):247. doi: 10.3390/v13020247. Viruses. 2021. PMID: 33557418 Free PMC article.
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.
Tea F, Ospina Stella A, Aggarwal A, Ross Darley D, Pilli D, Vitale D, Merheb V, Lee FXZ, Cunningham P, Walker GJ, Fichter C, Brown DA, Rawlinson WD, Isaacs SR, Mathivanan V, Hoffmann M, Pöhlman S, Mazigi O, Christ D, Dwyer DE, Rockett RJ, Sintchenko V, Hoad VC, Irving DO, Dore GJ, Gosbell IB, Kelleher AD, Matthews GV, Brilot F, Turville SG. Tea F, et al. Among authors: irving do. PLoS Med. 2021 Jul 6;18(7):e1003656. doi: 10.1371/journal.pmed.1003656. eCollection 2021 Jul. PLoS Med. 2021. PMID: 34228725 Free PMC article.
82 results